Methyl-CpG Binding Domain Protein 1 (MBD1) Peptide
MBD1
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN979864
Aperçu rapide pour Methyl-CpG Binding Domain Protein 1 (MBD1) Peptide (ABIN979864)
Antigène
MBD1
(Methyl-CpG Binding Domain Protein 1 (MBD1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-MBD1 antibody (Catalog #: ARP40168_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MBD1 (Methyl-CpG Binding Domain Protein 1 (MBD1))
-
Sujet
-
MBD1 belongs to a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MBD1 can also repress transcription from methylated gene promoters. Five transcript variants of the MBD1 are generated by alternative splicing resulting in protein isoforms that contain one MBD domain, two to three cysteine-rich (CXXC) domains, and some differences in the COOH terminus. All five transcript variants repress transcription from methylated promoters, in addition, variants with three CXXC domains also repress unmethylated promoter activity. DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. Five transcript variants of the MBD1 are generated by alternative splicing resulting in protein isoforms that contain one MBD domain, two to three cysteine-rich (CXXC) domains, and some differences in the COOH terminus. All five transcript variants repress transcription from methylated promoters, in addition, variants with three CXXC domains also repress unmethylated promoter activity. MBD1 and MBD2 map very close to each other on chromosome 18q21.
Alias Symbols: RFT, PCM1, CXXC3
Protein Interaction Partner: ATF7IP,ATF7IP2,CHAF1A,SETDB1,ATF7IP,ATF7IP2,CBX5,CHAF1A,HDAC3,HIPK3,OASL,PIAS1,PIAS2,SETDB1,SMAD1,SMAD3,SMAD5,SMAD7,SMAD9,SUV39H1,ATF7IP,CBX4,CBX5,CHAF1A,RNF2,Rnf2,SUV39H1
Protein Size: 549 -
Poids moléculaire
- 60 kDa
-
ID gène
- 4152
-
NCBI Accession
- NM_015844, NP_056669
Antigène
-
Vous êtes ici:
